Skip to main content

Advertisement

SpringerLink
Log in

Tocilizumab for focal segmental glomerulosclerosis secondary to multicentric Castleman’s disease

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Fajgenbaum DC, Uldrick TS, Bagg A, Frank D, Wu D, Srkalovic G, Simpson D, Liu AY, Menke D, Chandrakasan S, Lechowicz MJ, Wong RS, Pierson S, Paessler M, Rossi JF, Ide M, Ruth J, Croglio M, Suarez A, Krymskaya V, Chadburn A, Colleoni G, Nasta S, Jayanthan R, Nabel CS, Casper C, Dispenzieri A, Fossa A, Kelleher D, Kurzrock R, Voorhees P, Dogan A, Yoshizaki K, van Rhee F, Oksenhendler E, Jaffe ES, Elenitoba-Johnson KS, Lim MS (2017) International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease. Blood 129(12):1646–1657. https://doi.org/10.1182/blood-2016-10-746933

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Yuan XG, Hu W, Chen FF, Huang BF, Zhao XY (2011) Renal complications of Castleman’s disease: report of two cases and analysis of 75 cases. Clin Exp Nephrol 15(6):921–926. https://doi.org/10.1007/s10157-011-0499-9

    Article  PubMed  Google Scholar 

  3. Kawabata H, Kadowaki N, Nishikori M, Kitawaki T, Kondo T, Ishikawa T, Yoshifuji H, Yamakawa N, Imura Y, Mimori T, Matsumura Y, Miyachi Y, Matsubara T, Yanagita M, Haga H, Takaori-Kondo A (2013) Clinical features and treatment of multicentric castleman’s disease : a retrospective study of 21 Japanese patients at a single institute. J Clin Exp Hematop 53(1):69–77

    Article  PubMed  Google Scholar 

  4. Estrada CC, Paladugu P, Guo Y, Pace J, Revelo MP, Salant DJ, Shankland SJ, D’Agati VD, Mehrotra A, Cardona S, Bialkowska AB, Yang VW, He JC, Mallipattu SK (2018) Kruppel-like factor 4 is a negative regulator of STAT3-induced glomerular epithelial cell proliferation. JCI Insight 3(12). https://doi.org/10.1172/jci.insight.98214

  5. Savin VJ, Sharma M, Zhou J, Gennochi D, Fields T, Sharma R, McCarthy ET, Srivastava T, Domen J, Tormo A, Gauchat JF (2015) Renal and hematological effects of CLCF-1, a B-cell-stimulating cytokine of the IL-6 family. J Immunol Res 2015:714964. https://doi.org/10.1155/2015/714964

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo Bunkyo-ku, Tokyo, 113-8655, Japan

    Kazutoshi Ebisawa, Yosuke Masamoto, Junji Tokushige, Kazuhiro Toyama & Mineo Kurokawa

  2. Department of Nephrology and Endocrinology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo Bunkyo-ku, Tokyo, 113-8655, Japan

    Hiroshi Nishi, Kenjiro Honda & Masaomi Nangaku

  3. Department of Pathology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo Bunkyo-ku, Tokyo, 113-8655, Japan

    Munetoshi Hinata

  4. Department of Cell Therapy and Transplantation Medicine, The University of Tokyo Hospital, 7-3-1 Hongo Bunkyo-ku, Tokyo, 113-8655, Japan

    Mineo Kurokawa

Authors
  1. Kazutoshi Ebisawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yosuke Masamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Junji Tokushige
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hiroshi Nishi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kenjiro Honda
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Munetoshi Hinata
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Kazuhiro Toyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Masaomi Nangaku
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Mineo Kurokawa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mineo Kurokawa.

Ethics declarations

Full informed consent was obtained from the patient in this report for the treatment. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Conflict of interest

Kazuhiro Toyama has the following financial relationship to disclose. Honoraria (lecture fee) from Chugai Pharmaceutical Co., Ltd. (tocilizumab). Masaomi Nangaku has the following financial relationships to disclose. Honoraria (lecture fee) and research funding from Chugai Pharmaceutical Co., Ltd. (tocilizumab). Mineo Kurokawa has the following financial relationship to disclose. Research funding from Chugai Pharmaceutical Co., Ltd. (tocilizumab). The other authors (Drs K.E., Y.M., J.T., H.N., K.H., M.H.) declared that they had no relevant financial relationships to disclose.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ebisawa, K., Masamoto, Y., Tokushige, J. et al. Tocilizumab for focal segmental glomerulosclerosis secondary to multicentric Castleman’s disease. Ann Hematol 98, 1995–1997 (2019). https://doi.org/10.1007/s00277-019-03616-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-019-03616-y

Search

Navigation